International Collaboration on Brink of Resurrecting Northern White Rhinos
An international collaboration called BioRescue has taken a step forward in bringing back the Northern…
17/01/2020 - 3 minutes
News and Trends
ADVERTISEMENT
Do you want to remove this advert? Become a member!
Biotech Investment Firm Jeito Capital Launches with €200M Fund
The French investment firm Jeito Capital has launched this week with a €200M fund that…
16/01/2020 - 2 minutes
BioNTech Expands Cancer Portfolio With US Biotech Acquisition
German cancer specialist BioNTech will acquire US T-cell therapy biotech Neon Therapeutics in a deal…
16/01/2020 - 2 minutes
Adaptimmune to Take Off-The-Shelf CAR-T to Phase I with Astellas
The UK biotech Adaptimmune Therapeutics has inked a deal worth up to €806M with Japanese…
15/01/2020 - 2 minutes
Update: Horizon Discovery to Offer Partners Precise CRISPR Gene Editing
Update (14/01/20): Horizon Discovery will offer partners access to a precise version of CRISPR gene…
14/01/2020 - 3 minutes
Bluebird Bio Launches First Gene Therapy for Beta Thalassemia in Germany
The US company bluebird bio has launched the first gene therapy for the blood disorder…
14/01/2020 - 3 minutes
KaNDy’s Menopause Treatment Tackles Hot Flashes in Phase II
A non-hormonal menopause treatment that targets the brain’s ‘thermostat’, developed by the UK company KaNDy…
13/01/2020 - 3 minutes
Eyevensys’ Gene Therapy for Blindness Boosted with €27M Series B
The French company Eyevensys has raised €27M to fund the launch of a phase II…
10/01/2020 - 3 minutes
Emergex Vaccines Secures €10M to Advance Synthetic Vaccine Development
The UK biotech Emergex Vaccines has raised over €9.9M in a Series A funding round,…
09/01/2020 - 3 minutes
French Biotech Raises €19M to Hit Phase I with Cancer Immunotherapy
Alderaan Biotechnology has raised an €18.5M Series A round to push its lead cancer immunotherapy…
09/01/2020 - 2 minutes
Therachon Founders Spin Out New Rare Disease Biotech With €31M Investment
The founders of Swiss biotech Therachon have launched a new company called VectivBio, also based…
08/01/2020 - 2 minutes
NorthSea Therapeutics Raises €36M to Complete NASH Phase II Trial
The Dutch biotech NorthSea Therapeutics has raised a €36M ($40M) Series B round to fund…
08/01/2020 - 2 minutes
